Fundz

Who to call at Cytonus Therapeutics, Inc., and when

Fundz watches for the moments Cytonus Therapeutics, Inc. starts buying, and tells you who to reach.

  • An alert the day Cytonus Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cytonus Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cytonus Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Cytonus Therapeutics, Inc. is looking to raise $50,000

Oct 27, 2026

Target Amount

$50,000

Deadline

Apr 30, 2027

CIK0001761468
File Number007-00033

Issuer ContactFrom SEC filing

Legal nameCytonus Therapeutics, Inc.
Websiteaxiombio.co
Address10956 Deering Street
San Diego, CA, 92126

Issuer Information

Issuer

Cytonus Therapeutics, Inc.

Location

3280 grey hawk ct.

san diego, california, united states

About

Cytonus is reinventing drug-discovery and drug-delivery by questioning the principled approaches of pharmacodynamics (physiological effects of drugs) that has failed patients since the start of medicine. With a revolutionary platform technology called the Cargocyte, we believe the days of flooding the body with medicines with a hope and prayer to effect disease is not only antiquated, it is scientifically flawed. With a combination of precision drug delivery and in-vivo drug production the Cargocyte platform enables science and medicines to new level of effectiveness without compromising safety for patients.

G2 High Performer Badge

⚡ Your AI Catches Every Buying Signal

While you sleep, we analyze 1,000+ companies across all strategic moves.

Set your ICP once, then wake up to:

• Companies that just hired key executives

• Fresh funding rounds AND acquisitions

• Product launches & new partnerships

• Your top matches from ALL momentum signals

2 to 50 AI-scored leads daily, by plan

Trusted by sales, BD, and investment teams at Oracle, HubSpot, and more.

Campaign Status

Filing TypeRegulation CF (C)
Target Amount$50,000
Securities TypePreferred Stock
StateCA

Time Remaining

184 days remaining

View SEC Filing

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cytonus Therapeutics, Inc. opens a raise, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Remo
Senior decision-maker at this company
••••••••@••••••••

See Remo's verified email →

Create an account to reveal verified emails

This company raised through a public offering. Fundz reads the filing itself, not a press release.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.